Inventiva (IVA) Operating Expenses (2019 - 2022)
Inventiva (IVA) posted quarterly Operating Expenses of -$18.0 million for Q2 2021, down 95.75% year-over-year from -$423.3 million in Q2 2020, and down 564.09% quarter-over-quarter from -$2.7 million in Q1 2021.
Analysis
Inventiva (IVA) Operating Expenses (2019 - 2022) Analysis & Trends
Inventiva's Operating Expenses history runs 3 years deep, the most recent figure standing at -$18.0 million for Q2 2021.
- In Q2 2021, Operating Expenses fell 95.75% year-over-year to -$18.0 million; the TTM figure through Sep 2022 stood at -$18.0 million (changed N/A YoY), while the FY2025 annual figure was $157.1 million, up 37.74% from the prior year.
- Operating Expenses for Q2 2021 stood at -$18.0 million, down from -$2.7 million in the prior quarter.
- The five-year high for Operating Expenses was -$14351.2 in Q1 2020, with the low at -$44.1 million in Q4 2019.
- The 3-year median for Operating Expenses is -$13.6 million (2020), against an average of -$18.7 million.
- The sharpest annual moves came in 2020 and 2021: Operating Expenses rose 12.98% in 2020, then tumbled 18794.71% in 2021.
- Inventiva's Operating Expenses stood at -$44.1 million in 2019, then advanced by 12.98% to -$38.4 million in 2020, then soared by 53.12% to -$18.0 million in 2021.
- Business Quant data shows IVA's Operating Expenses at -$18.0 million in Q2 2021, -$2.7 million in Q1 2021, and -$38.4 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.05 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 960.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 505.13 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.21 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 541.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -283,628.77 |
| Jun 30, 2021 | -18.01 Mn |
| Mar 31, 2021 | -11.98 Mn |
| Dec 31, 2020 | -38.41 Mn |
| Jun 30, 2020 | -9.20 Mn |
| Mar 31, 2020 | -8.40 Mn |
| Dec 31, 2019 | -44.14 Mn |